Insider buy at Incyte (INCY) is Significant Breaks Selling Trend of Last Quarter

Friday, September 08, 2017 10:15 PM ET

Insider buy at Incyte (INCY) is Significant Breaks Selling Trend of Last Quarter

An insider — Baker Bros Advisors Lp, 10% Owner and Director — acquired 100,000 shares of Incyte having a market value of approximately $13,200,000 today, as disclosed in a form 4 document filed with the SEC. There was one insider buy/sell transaction in the past 90 days prior to this transaction which resulted in the sale of 6,000 shares. Adding the most recent activity to this 90-day history indicates insider trades have been net purchases of 94,000 shares and have averaged 53,000 shares per transaction over this time period.

The number of insider buy/sell trades at Incyte is higher than that of the 181 peer company average over the last 90-day period. The Biotechnology & Medical Research peer group saw 199 buy/sell trades during this period for an average of 1.1 transactions per company. However, the number of shares traded per transaction by Incyte insiders is lower than its peers. Within the peer group there were 7,824,449 shares purchased and 35,372,342 shares sold with company insiders having sold 138,432 shares on average over this time period.

The data sourced in evaluating and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.

Using proprietary artificial intelligence methods, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at info@uptickdata.com. Copyright 2017 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.